Κυριακή 1 Σεπτεμβρίου 2019


Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus
Abstract Purpose Long noncoding RNAs (LncRNAs) are widely investigated in various diseases as a novel type of biomarkers. We aimed to elucidate the diagnostic values of lncRNAs in patients with type 2 diabetes mellitus (T2DM). Methods We comprehensively searched PubMed, Web of Science, EMBASE, CBM, Scopus, and the Cochrane Library databases...
International journal of basic and clinical endocrinology
Sat Aug 31, 2019 09:45
Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
International journal of basic and clinical endocrinology
Sat Aug 31, 2019 09:45
Answer to the readers of “Successful radiofrequency ablation strategies for benign thyroid nodules”
International journal of basic and clinical endocrinology
Sat Aug 31, 2019 09:45
Ethnic differences in body composition, sociodemographic characteristics and lifestyle in people with type 2 diabetes mellitus living in Italy
Abstract This study aimed to compare immigrants and Italian natives with type 2 diabetes mellitus (DM2) in terms of anthropometric parameters and lifestyle-related characteristics and to investigate the relationship between ethnicity and glycemic control in men and women with DM2 living in Italy. The sample included 100 immigrants (55 Albanians and 45 Africans) and 100 Italians, followed by the Public Health Clinics of Rimini. The association of ethnicity with sex, socioeconomic...
International journal of basic and clinical endocrinology
Sat Aug 31, 2019 09:45
Dipeptidyl peptidase-4 inhibitors do not alter GH/IGF-I axis in adult diabetic patients
Abstract Purpose Incretin-based therapies have been introduced in clinical practice for type 2 diabetes mellitus (T2DM) treatment in the last few years. Current available medications of this class include glucagon-like peptide 1 (GLP-1) receptor agonists and dipeptidyl peptidase-4 (DPP-4) inhibitors. In addition to GLP-1, DPP-4 is able to inactivate many others peptides as hypothalamic growth hormone-releasing hormone (GHRH). The aim of...
Journal of Endocrinological Investigation
Sat Aug 31, 2019 03:00

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου